Formylated peptides are important virulence factors in staphylococcus aureus arthritis in mice

Journal of Infectious Diseases

Volumn 205, Issue 2, 2012, Pages 305-311

  Gjertsson, Inger ^a   Jonsson, Ing Marie ^a   Peschel, Andreas ^b   Tarkowski, Andrej ^a   Lindholm, Catharina ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FORMYLPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL ARTHRITIS; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM MUTANT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; IN VIVO STUDY; JOINT DESTRUCTION; KIDNEY; MOUSE; NEUTROPHIL; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STRAIN DIFFERENCE; SYNOVIUM; WEIGHT REDUCTION; WILD TYPE;

ANIMALS; ARTHRITIS, INFECTIOUS; CHEMOTACTIC FACTORS; CHEMOTAXIS, LEUKOCYTE; FEMALE; HINDLIMB; HYDROXYMETHYL AND FORMYL TRANSFERASES; INTERLEUKIN-6; KIDNEY; MICE; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; PEROXIDASE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SYNOVIAL MEMBRANE; WEIGHT LOSS;

EID: 84555195626     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir713     Document Type: Article

References (20)

1. Goldenberg DL, Reed JI. Bacterial arthritis. N Engl J Med 1985; 312:764-71. (Pubitemid 15104798)
2. Tarkowski A. Infection and musculoskeletal conditions: infectious arthritis. Best Pract Res Clin Rheumatol 2006; 20:1029-44.
3. Caporali R, Caprioli M, Bobbio-Pallavicini F, Montecucco C. DMARDS and infections in rheumatoid arthritis. Autoimmun Rev 2008; 8:139-43.
4. Jamsen E, Huhtala H, Puolakka T, Moilanen T. Risk factors for infection after knee arthroplasty. A register-based analysis of 43,149 cases. J Bone Joint Surg Am 2009; 91:38-47.
5. Harvath L. Neutrophil chemotactic factors. Exs 1991; 59:35-52.
6. Kozak M. Initiation of translation in prokaryotes and eukaryotes. Gene 1999; 234:187-208. (Pubitemid 29298181)
7. Schiffmann E, Corcoran BA, Wahl SM. N-formylmethionyl peptides as chemoattractants for leucocytes. Proc Natl Acad Sci USA 1975; 72:1059-62.
8. Southgate EL, He RL, Gao JL, Murphy PM, Nanamori M, Ye RD. Identification of formyl peptides from Listeria monocytogenes and Staphylococcus aureus as potent chemoattractants for mouse neutrophils. J Immunol 2008; 181:1429-37.
9. Rot A, Henderson LE, Leonard EJ. Staphylococcus aureus-derived chemoattractant activity for human monocytes. J Leukoc Biol 1986; 40:43-53. (Pubitemid 16067613)
10. Marasco WA, Phan SH, Krutzsch H, et al. Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli. J Biol Chem 1984; 259:5430-9. (Pubitemid 14144994)
11. Durr MC, Kristian SA, Otto M, et al. Neutrophil chemotaxis by pathogen-associated molecular patternsdformylated peptides are crucial but not the sole neutrophil attractants produced by Staphylococcus aureus. Cell Microbiol 2006; 8:207-17. (Pubitemid 43356044)
12. Margolis PS, Hackbarth CJ, Young DC, et al. Peptide deformylase in Staphylococcus aureus: resistance to inhibition is mediated by mutations in the formyltransferase gene. Antimicrob Agents Chemother 2000; 44:1825-31. (Pubitemid 30422931)
13. Tarkowski A, Collins LV, Gjertsson I, et al. Model systems: modeling human staphylococcal arthritis and sepsis in the mouse. Trends Microbiol 2001; 9:321-6. (Pubitemid 32575276)
14. Abdelnour A, Arvidson S, Bremell T, Ryden C, Tarkowski A. The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model. Infect Immun 1993; 61:3879-85. (Pubitemid 23260062)
15. Bremell T, Abdelnour A, Tarkowski A. Histopathological and serological progression of experimental Staphylococcus aureus arthritis. Infect Immun 1992; 60:2976-85.
16. Verdrengh M, Tarkowski A. Role of neutrophils in experimental septicemia and septic arthritis induced by Staphylococcus aureus. Infect Immun 1997; 65:2517-21. (Pubitemid 27264071)
17. Wang R, Braughton KR, Kretschmer D, et al. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med 2007; 13:1510-14. (Pubitemid 350224240)
18. Kretschmer D, Gleske AK, Rautenberg M, et al. Human formyl peptide receptor 2 senses highly pathogenic Staphylococcus aureus. Cell Host Microbe 2010; 7:463-73.
19. Guillon JM, Mechulam Y, Schmitter JM, Blanquet S, Fayat G. Disruption of the gene for Met-tRNA(fMet) formyltransferase severely impairs growth of Escherichia coli. J Bacteriol 1992; 174:4294-301.
20. Giglione C, Pierre M, Meinnel T. Peptide deformylase as a target for new generation, broad spectrum antimicrobial agents. Mol Microbiol 2000; 36:1197-205. (Pubitemid 30449958)